Psychiatry and Neurology, Epilepsy · Orange, CA
NPI
1215909486
Since 2006
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
101 the City Dr S, Pavilion I, First Floor
Orange, CA, 92868
Phone (714) 456-6510
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
391 services
Medicare patients, 2024
186
Average age 61
Drug cost, 2024
$1.8M
2,424 prescriptions
Company payments, 2025
$15K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mona Sazgar was code 99214 (office e&m - established), 143 times for 82 patients. In total Mona Sazgar billed 391 services in 31 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 143 | 82 | $68.81 | $9,839 |
| 95720 Neurologic | Facility | 94 | 52 | $173.70 | $16K |
| 95816 Neurologic | Facility | 17 | 17 | $45.74 | $778 |
| 95970 Electrical Nerve Conductivity | Facility | 14 | 11 | $16.27 | $228 |
By year: 2022 $48K for 477 services; 2023 $37K for 406 services; 2024 $37K for 391 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mona Sazgar prescribed most often to Medicare patients was Lamotrigine, with 298 prescriptions and refills. In total Mona Sazgar wrote 2,424 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 298 | 472 | 44 | $5,439 |
| Levetiracetam Generic | 254 | 467 | 45 | $13K |
| Briviact Brivaracetam | 143 | 146 | 16 | $224K |
| Lacosamide Generic | 137 | 153 | 18 | $16K |
| Topiramate Generic | 134 | 202 | 20 | $10K |
| Clobazam Generic | 118 | 146 | 19 | $15K |
| Xcopri Cenobamate | 102 | 105 | 11 | $138K |
| Divalproex Sodium Generic | 99 | 183 | 18 | $8,447 |
| Divalproex Sodium Er Divalproex Sodium | 98 | 158 | 15 | $6,452 |
| Clonazepam Generic | 64 | 66 | 11 | $545 |
| Zonisamide Generic | 64 | 108 | Under 11 | $2,827 |
| Levocarnitine Generic | 57 | 84 | Under 11 | $13K |
| Epidiolex Cannabidiol (Cbd) | 55 | 60 | Under 11 | $305K |
| Felbamate Generic | 46 | 62 | Under 11 | $36K |
| Phenobarbital Generic | 45 | 45 | Under 11 | $2,675 |
Brand drugs: 581 claims; generic drugs: 1,798 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mona Sazgar $15K ($15K in general payments such as food, travel and fees) from 5 companies. The largest payer was Neurelis, Inc. with $8,104.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.